Peak Pharma Commercial Partners, a United States-based investment fund that deals with the acquisition and growth of branded, generic and over-the-counter pharmaceutical products, has established and started operations of Resilia Pharmaceuticals Inc, it was reported on Monday.

Resilia's product range includes Ecoza (econazole nitrate) topical foam, Recedo topical gel, Neosalus foam and Neocera, the ceramide version of Neosalus.

Presently, these products are approved and marketed in the United States and the company says that they have been prescribed and used safely and effectively by thousands of patients.